|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2009-3-13
|
|
pubmed:abstractText |
Atomoxetine, a selective noradrenaline reuptake inhibitor (SNRI) licensed for the treatment of attention-deficit/hyperactivity disorder (ADHD), has been shown to improve response inhibition in animals, healthy volunteers, and adult patients. However, the mechanisms by which atomoxetine improves inhibitory control have yet to be determined.
|
|
pubmed:grant |
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
1873-2402
|
|
pubmed:author |
pubmed-author:BullmoreEdward TET,
pubmed-author:ChamberlainSamuel RSR,
pubmed-author:CraigKevinK,
pubmed-author:Del CampoNataliaN,
pubmed-author:GrantJon EJE,
pubmed-author:HampshireAdamA,
pubmed-author:MüllerUlrichU,
pubmed-author:RegenthalRalfR,
pubmed-author:RobbinsTrevor WTW,
pubmed-author:RoiserJonathan PJP,
pubmed-author:RubiaKatyaK,
pubmed-author:SahakianBarbara JBJ,
pubmed-author:SucklingJohnJ
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
65
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
550-5
|
|
pubmed:meshHeading |
pubmed-meshheading:19026407-Adrenergic Uptake Inhibitors,
pubmed-meshheading:19026407-Adult,
pubmed-meshheading:19026407-Double-Blind Method,
pubmed-meshheading:19026407-Frontal Lobe,
pubmed-meshheading:19026407-Humans,
pubmed-meshheading:19026407-Inhibition (Psychology),
pubmed-meshheading:19026407-Magnetic Resonance Imaging,
pubmed-meshheading:19026407-Male,
pubmed-meshheading:19026407-Middle Aged,
pubmed-meshheading:19026407-Placebos,
pubmed-meshheading:19026407-Propylamines,
pubmed-meshheading:19026407-Reaction Time
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Atomoxetine modulates right inferior frontal activation during inhibitory control: a pharmacological functional magnetic resonance imaging study.
|
|
pubmed:affiliation |
Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrooke's Hospital, University of Cambridge, Cambridge, UK. srchamb@gmail.com
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Research Support, N.I.H., Extramural
|
